News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CAS Medical Systems, Inc. (CASM) Announces Publication of Study Using FORE-SIGHT(R) to Improve Identification of Children With Sickle Cell Disease at Highest Risk for Neurologic Injury in Pediatric Blood and Cancer Journal



6/28/2012 9:25:13 AM

BRANFORD, Conn., June 28, 2012 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED) today announced the online early publication of the study "Cerebral Tissue Hemoglobin Saturation in Children With Sickle Cell Disease" in the Pediatric Blood and Cancer journal. In an NIH-funded study, researchers used CASMED's FORE-SIGHT® Oximeter to measure absolute oxygen saturation levels in the brain of children with sickle cell disease (SCD) and found that cerebral oximetry is a useful non-invasive tool to identify those who are at risk for brain injury and could help guide neuroprotective therapies for these patients.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES